Baijin Life Science Holdings (HKG:1466) said it will delay the publication of its annual results for the year ended March 31, according to a late-Wednesday Hong Kong bourse filing.
Shares of the company were down about 1% in Thursday afternoon trade.
The company only assumed full operational control of the subsidiaries earlier this week and additional time is needed for its auditors and management to complete the audit, the company said.
It now expects to publish the results by July 25.
Baijin said it is not aware of any material issues affecting the audit or any disputes with its auditors. However, the delay will result in non-compliance with the Hong Kong listing rules.
If results are not published by June 30, trading in the company's shares will be suspended from July 2, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.